Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
ContraFect Corporation Stock Forecast NASDAQ:CFRX
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-02-16 | 150.7% | SVB Leerink | $14.00 $9.00 | Maintains | Outperform |
| 2022-02-02 | 81.06% | WBB Securities | $6.50 | Upgrades | Speculative Buy Buy |
| 2021-09-09 | 289.97% | SVB Leerink | $14.00 | Initiates Coverage On | Outperform |
| 2021-03-31 | 81.06% | WBB Securities | $6.50 | Initiates Coverage On | Speculative Buy |
| 2020-06-09 | 234.26% | Mizuho | $12.00 | Initiates Coverage On | Buy |
| 2020-06-09 | 317.83% | Cantor Fitzgerald | $15.00 | Initiates Coverage On | Overweight |
CFRX Stock Trend
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled.
Given the current short-term trend, the stock is expected to rise 5.08% during the next 3 months and, with a 90% probability hold a price between $3.14 and $4.75 at the end of this 3-month period.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-25 | $2.99 | $3.76 | $4.53 |
| 2022-05-26 | $2.99 | $3.76 | $4.53 |
| 2022-05-27 | $3.00 | $3.76 | $4.53 |
| 2022-05-31 | $3.00 | $3.77 | $4.54 |
| 2022-06-01 | $3.00 | $3.77 | $4.54 |
| 2022-06-02 | $3.01 | $3.78 | $4.54 |
| 2022-06-03 | $3.01 | $3.78 | $4.55 |
| 2022-06-06 | $3.01 | $3.78 | $4.55 |
| 2022-06-07 | $3.02 | $3.79 | $4.55 |
| 2022-06-08 | $3.02 | $3.79 | $4.56 |
| 2022-06-09 | $3.02 | $3.79 | $4.56 |
| 2022-06-10 | $3.03 | $3.80 | $4.57 |
| 2022-06-13 | $3.03 | $3.80 | $4.57 |
| 2022-06-14 | $3.04 | $3.80 | $4.57 |
| 2022-06-15 | $3.04 | $3.81 | $4.58 |
| 2022-06-16 | $3.04 | $3.81 | $4.58 |
| 2022-06-17 | $3.05 | $3.81 | $4.58 |
| 2022-06-21 | $3.05 | $3.82 | $4.59 |
| 2022-06-22 | $3.05 | $3.82 | $4.59 |
| 2022-06-23 | $3.06 | $3.83 | $4.59 |
| 2022-06-24 | $3.06 | $3.83 | $4.60 |
| 2022-06-27 | $3.06 | $3.83 | $4.60 |
| 2022-06-28 | $3.07 | $3.84 | $4.60 |
| 2022-06-29 | $3.07 | $3.84 | $4.61 |
| 2022-06-30 | $3.07 | $3.84 | $4.61 |
| 2022-07-01 | $3.08 | $3.85 | $4.62 |
| 2022-07-05 | $3.08 | $3.85 | $4.62 |
| 2022-07-06 | $3.09 | $3.85 | $4.62 |
| 2022-07-07 | $3.09 | $3.86 | $4.63 |
| 2022-07-08 | $3.09 | $3.86 | $4.63 |
ContraFect Corporation, a biotechnology company, focuses on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, a lysin that completed Phase 1 human clinical trials for the treatment of Staph aureus bacteremia, including endocarditis caused by methicillin-resistant or methicillin-susceptible Staph aureus; ... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
